Nutritional modulation of the cell cycle and breast cancer

Endocrine-Related Cancer

Volumn 11, Issue 4, 2004, Pages 603-622

  Hilakivi Clarke, L ^a   Wang, C ^a   Kalil, M ^a   Riggins, R ^a   Pestell, R G ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ARF PROTEIN; BRCA1 PROTEIN; CELL NUCLEUS RECEPTOR; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; E1A PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GENISTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROTEIN P16INK4A; PROTEIN P19ARF; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; STEROID HORMONE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; BIRTH WEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CALORIC RESTRICTION; CANCER INCIDENCE; CANCER MORTALITY; CELL CYCLE; CELL STRAIN MCF 7; DIET; FEMALE; HUMAN; LIPID DIET; MITOSIS INHIBITION; NUTRITION; ONCOGENE MYC; ONCOGENE RAS; POSTMENOPAUSE; PREPUBERTY; REVIEW; UNITED STATES;

ANDROGENS; BREAST NEOPLASMS; CELL CYCLE; CYCLIN D1; CYCLIN-DEPENDENT KINASES; DIET; ESTROGENS; FATTY ACIDS, UNSATURATED; FEMALE; GENISTEIN; HUMANS; PPAR GAMMA; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; VITAMIN A;

EID: 11244346075     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00665     Document Type: Review

References (226)

1. Adlercreutz H 1995 Phytoestrogens: epidemiology and a possible role in cancer protection. Environmental Health Perspectives 103 103-112.
2. Adlercruetz CH, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, Hamalainen E, Markkanen MH, Makela TH, Wahala KT, Hase TA & Fotsis T 1996 Soybean phytoestrogen intake and cancer risk. Journal of Nutrition 125 757S-770S.
3. Agarwal R 2000 Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochemical Pharmacology 60 1051-1059.
4. Allred CD, Allred KF, Ju YH, Virant SM & Helferich WG 2001 Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Research 61 5045-5050.
5. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F & Weisz A 1996 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12 2315-2324.
6. Amos B & Lotan R 1990 Retinoid-sensitive cells and cell lines. Methods in Enzymology 190 217-225.
7. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257 79-83.
8. Barnes S, Peterson G, Grubbs C & Setchell K 1994 Potential role of dietary isoflavones in the prevention of cancer. In Diet and Cancer: Markers, Prevention, and Treatment, pp 135-147. Ed. MM Jacobs. New York: Plenum Press.
9. Bennett FC & Ingram DM 1990 Diet and female sex hormones concentrations: an intervention study for the type of fat consumed. American Journal of Clinical Nutrition 52 808-812.
10. Berkey CS, Frazier AL, Gardner JD & Colditz G 1999 Adolescence and breast carcinoma risk. Cancer 85 2400-2409.
11. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ & Tilley WD 1995 Androgens induce divergent proliferative responses in human breast cancer cell lines. Journal of Steroid Biochemistry and Molecular Biology 52 459-467.
12. Boccuzzi G, Brignardello E, di Monaco M, Forte C, Leonardi L & Pizzini A 1992 Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. Anticancer Research 12 799-803.
13. Bohlke K, Spiegelman D, Trichopoulou A, Katsouyanni K & Trichopoulos D 1999 Vitamins A, C, and E and the risk of breast cancer: results from a case-control study in Greece. British Journal of Cancer 79 23-29.
14. Bouker KB & Hilakivi-Clarke L 2000 Genistein: does it prevent or promote breast cancer? Environmental Health Perspectives 108 701-708.
15. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S & Yaffe MJ 2001 Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Current Oncology Reports 3 314-321.
16. van den Brandt PA, Van't Veer P, Goldbohm RA, Dorant E, Volovics A, Hermus RJJ & Sturmans F 1993 A prospective cohort study on dietary fat and the risk of postmenopausal breast cancer. Cancer Research 53 75-82.
17. Brockman JA, Gupta RA & Dubois RN 1998 Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115 1049-1055.
18. Brodie A 2003 Aromatase inhibitor development and hormone therapy: a perspective. Seminars in Oncology 30 12-22.
19. Cabanes A, Wang M, Olivo S, de Assis S, Gustafsson JA, Khan G & Hilakivi-Clarke L 2004 Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25 741-748.
20. Caygill CPJ, Charlett A & Hill MJ 1996 Fat, fish, fish oil, and cancer. British Journal of Cancer 74 159-164.
21. Chen ZY & Istfan NW 2001 Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukotrienes and Essential Fatty Acids 64 67-73.
22. Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M & Marshall GM 2003 Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. International Journal of Cancer 105 856-867.
23. Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ, Colditz GA & Willett WC 2003a Premenopausal fat intake and risk of breast cancer. Journal of the National Cancer Institute 95 1079-1085.
24. Cho E, Spiegelman D, Hunter DJ, Chen WY, Zhang SM, Colditz GA & Willett WC 2003b Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiology Biomarkers and Prevention 12 713-720.
25. Cleary ML & Maihle NJ 1997 The role of body mass index in the relative risk of developing premenopausal breast cancer. Proceedings of the Society for Experimental Biology and Medicine 216 28-43.
26. Cohen LA, Zhao Z & Pittman BSJA 2000 Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis 21 929-935.
27. Constantinou AI, Mehta RG & Vaughan A 1996 Inhibition of N-methyl-N-nitroisourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Research 16 3293-3298.
28. Cotroneo MS, Wang J, Fritz WA, Eltoum IE & Lamartiniere CA 2002 Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23 1467-1474.
29. D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee H-W, DePinho RA & Pestell RG 2003 The role of Ink4a/ Arf in ErbB2 mammary gland tumorigenesis. Cancer Research 63 3395-3402.
30. Dang ZC, Audinot V, Papapoulos SE, Boutin JA & Lowik CW 2003 Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. Journal of Biological Chemistry 278 962-967.
31. Davis VL, Couse JF, Goulding EH, Power SG, Eddy EM & Korach KS 1994 Aberrant reproductive phenotypes evident in transgenic mice expressing the wild-type mouse estrogen receptor. Endocrinology 135 379-386.
32. Dawson MI, Hobbs PD, Jong L, Xiao D, Chao WR, Pan C & Zhang XK 2000 sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity. Bioorganic and Medical Chemistry Letters 10 1307-1310.
33. Dees C, Foster JS, Ahamed S & Wimalasena J 1997 Dietary estrogens stimulate human breast cells to enter the cell cycle. Environmental Health Perspectives 105 (Suppl 3) 633-636.
34. Dietze EC, Troch MM, Bowie ML, Yee L, Bean GR & Seewaldt VL 2003 CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. Biochemical and Biophysical Research Communications 302 841-848.
35. Dirx MJ, van den Brandt PA, Goldbohm RA & Lumey LH 1999 Diet in adolescence and the risk of breast cancer: results of The Netherlands Cohort Study. Cancer Causes and Control 10 189-199.
36. Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich PO Jr, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A & Taylor PR 2003 Diet and sex hormones in girls: findings from a randomized controlled clinical trial. Journal of the National Cancer Institute 95 132-141.
37. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J & Desreumaux P 2002 Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360 1410-1418.
38. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB & Korach KS 1996 Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137 4796-4805.
39. Eid A & Berry EM 1988 The relationship between dietary fat, adipose tissue composition, and neoplasms of the breast. Nutrition and Cancer 11 173-177.
40. Eisen A & Weber BL 1998 Recent advances in breast cancer biology. Current Opinion in Oncology 10 486-491.
41. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D & Adami HO 1995 Perinatal characteristics and adult mammographic patterns. International Journal of Cancer 61 177-180.
42. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D & Koeffler HP 1998a Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. PNAS 95 8806-8811.
43. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D & Koeffler HP 1998b Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. PNAS 95 8806-8811.
44. Fahraeus R & Lane DP 1999 The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts. EMBO Journal 18 2106-2118.
45. Fairfield KM & Fletcher RH 2002 Vitamins for chronic disease prevention in adults: scientific review. Journal of the American Medical Association 287 3116-3126.
46. Fan S, Wang J-A, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID & Rosen EM 1999 BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284 1354-1356.
47. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID & Rosen EM 2000 Alcohol stimulates estrogen receptor signaling in human breast cancer cells lines. Cancer Research 60 5635-5639.
48. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG & Rosen EM 2001 Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20 77-87.
49. Fay MP, Freedman LS, Clifford CK & Midthune DN 1997 Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Research 57 3979-3988.
50. Finstad HS, Kolset SO, Holme JA, Wiger R, Farrants AK, Blomhoff R & Drevon CA 1994 Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood 84 3799-3809.
51. Fitzgibbons PL, Henson DE & Hutter RVP 1998 Benign breast changes and risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Archives of Pathology and Laboratory Medicine 122 1053-1055.
52. Flegal KM, Carroll MD, Ogden CL & Johnson CL 2002 Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 288 1723-1727.
53. Fontana JA & Rishi AK 2002 Classical and novel retinoids: their targets in cancer therapy. Leukemia 16 463-472.
54. Foster JS & Wimalasena J 1996 Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Molecular Endocrinology 10 488-498.
55. Freedman LS, Clifford CK & Messina M 1990 Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: a review. Cancer Research 50 5710-5719.
56. Fu M, Wang C, Wang J, Zafonte B, Lisanti MP & Pestell RG 2002 Acetylation in hormone signaling and the cell-cycle. Cytokine and Growth Factor Reviews 13 259-276.
57. Garland M, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Spiegelman D, Speizer F & Willett WC 1998 Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. American Journal of Epidemiology 147 636-643.
58. Gerhard I, Vollmar B, Runnebaum B, Klinga K, Haller U & Kubli F 1987 Weight percentile at birth: II prediction by endocrinological and sonographic measurements. European Journal of Obstetrics, Gynecology and Reproductive Biology 26 313-328.
59. Goldin BR, Adelercreutz H, Gorbach SL & Warram JH 1982 Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New England Journal of Medicine 307 1452-1547.
60. Gudas JM, Nguyen H, Li T & Cowan KH 1995 Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Research 55 4561-4565.
61. Gustafsson JA 1998 Therapeutic potential of selective estrogen receptor modulators. Current Opinion in Chemical Biology 2 508-511.
62. Hamilton AS & Mack TM 2003 Puberty and genetic susceptibility to breast cancer in a case-control study in twins. New England Journal of Medicine 348 2313-2322.
63. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL & Speizer FE 1998 Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 90 1292-1299.
64. Hilakivi-Clarke L, Onojafe I & Cho E 1996a High-fat diet induces aggressive behavior in male mice and rats. Life Sciences 58 1653-1660.
65. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Clarke R & Lippman M 1996b Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. Journal of the National Cancer Institute 88 1821-1827.
66. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E & Lippman ME 1997 A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. PNAS 94 9372-9377.
67. Hilakivi-Clarke L, Raygada M, Onojafe I, Cho E, Russo I, Skaar T & Clarke R 1998 Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. British Journal of Cancer 80 1682-1688.
68. Hilakivi-Clarke LA, Cho E, Onojafe I, Raygada M & Clarke R 1999 Maternal exposure to genistein during pregnancy increases mammary tumorigenesis in female rat offspring. Oncology Reports 6 1089-1095.
69. Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB & Clarke R 2002a Do estrogens always increase breast cancer risk? Journal of Steroid Biochemistry and Molecular Biology 80 163-174.
70. Hilakivi-Clarke L, Cho E, Cabanes A, Olivo S, DeAssis S, Helferich WG, Lippman ME & Clarke R 2002b Modulation of pregnancy estrogen levels by maternal dietary exposure to soy isolate or n-3 polyunsaturated fatty acid and breast cancer risk among female rat offspring. Clinical Cancer Research 8 3601-3610.
71. Hilakivi-Clarke L, Forsen T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C & Barker DJ 2001 Tallness and overweight during childhood have opposing effects on breast cancer risk. British Journal of Cancer 85 1680-1684.
72. Hirose M, Masuda A, Ito K, Kamano K & Okuyama H 1990 Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz[a] anthracene (DMBA) and 1,2-dimethylhydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis 11 731-735.
73. Holmes MD, Colditz GA, Hunter DJ, Hankinson SE, Rosner B, Speizer FE & Willett WC 2003 Meat, fish and egg intake and risk of breast cancer. International Journal of Cancer 104 221-227.
74. Hoskins K & Weber BL 1994 The biology of breast cancer. Current Opinion in Oncology 6 554-559.
75. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsoyanni K, Lubin F, Marubini E, Modan B & Rohan T 1990 Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. Journal of the National Cancer Institute 82 561-569.
76. Hsieh CY, Santell RC, Haslam SZ & Helferich WG 1998 Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Research 58 3833-3838.
77. Hu X, Juneja SC, Maihle NJ & Cleary MP 2002 Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. Journal of the National Cancer Institute 94 1704-1711.
78. Huang L & Li C 2000 Leptin: a multifunctional hormone. Cell Research 10 81-92.
79. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE & Willett WC 1997 Dual effects of weight and weight gain on breast cancer risk. Journal of the American Medical Association 278 1407-1411.
80. Hull KL & Harvey S 2002 GH as a co-gonadotropin: the relevance of correlative changes in GH secretion and reproductive state. Journal of Endocrinology 172 1-19.
81. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R & Arnold A 2001 Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. Journal of Clinical Investigation 107 1093-1102.
82. Jarvinen R, Knekt P, Seppanen R & Teppo L 1997 Diet and breast cancer risk in a cohort of Finnish women. Cancer Letters 114 251-253.
83. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS & Newbold RR 2002 Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biology of Reproduction 67 1285-1296.
84. Jiang W, Zhu Z & Thompson HJ 2003 Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats. Cancer Research 63 1228-1234.
85. Johns A, Freay AD, Fraser W, Korach KS & Rubanyi GM 1996 Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology 137 4511-4513.
86. Jordan VC 1998 Designer estrogens. Scientific American 279 60-67.
87. Jordan VC & Morrow M 1999 Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrine Reviews 20 253-278.
88. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR & Helferich WG 2001 Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. Journal of Nutrition 131 2957-2962.
89. Ju YH, Doerge DR, Allred KF, Allred CD & Helferich WG 2002 Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Research 62 2474-2477.
90. Kabuto M, Akiba S, Stevens R, Neriishi K & Land CE 2000 A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiology, Biomarkers and Prevention 9 575-579.
91. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K & Nagai R 2003 Molecular mechanism of insulin resistance and obesity. Experimental Biology and Medicine (Maywood) 228 1111-1117.
92. Karmali RA, March J & Fuchs C 1984 Effect of omega-3 fatty acids on growth of a rat mammary tumor. Journal of the National Cancer Institute 73 457-461.
93. Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL & Robertson JF 1999 Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clinical Cancer Research 5 2069-2076.
94. Kim H, Peterson TG & Barnes S 1998 Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. American Journal of Clinical Nutrition 68 (Suppl) 1418S-1425S.
95. Kinnunen T, Luoto R, Hemminki E, Gissler M & Hilakivi-Clarke L 2004 Pregnancy weight gain and breast cancer risk. (In Press).
96. Klein V, Chajes V, Germain E, Schulgen G, Pinault M, Malvy D, Lefrancq T, Fignon A, Le Floch O, Lhuillery C & Bougnoux P 2001 Low alpha-linolenic acid content of adipose breast tissue is associated with an increased risk of breast cancer. European Journal of Cancer 36 335-340.
97. Koeffler HP 2003 Peroxisome proliferator-activated receptor gamma and cancers. Clinical Cancer Research 9 1-9.
98. Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266 1524-1527.
99. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzy J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW & Smith EP 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 51 159-186.
100. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM & Fletcher JA 2000 PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma (corrected). Science 289 1357-1360.
101. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 863-870.
102. Kushi LH, Fee RM, Sellers TA, Zheng W & Folsom AR 1996 Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. American Journal of Epidemiology 144 165-174.
103. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR & Ewen ME 2003 A Mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114 323-334.
104. Lampe JW 2003 Isofavonoid and lignan phytoestrogens as dietary biomarkers. Journal of Nutrition 133 (Suppl 3) 956S-964S.
105. Lee IM, Blair SN, Allison DB, Folsom AR, Harris TB, Manson JE & Wing RR 2001 Epidemiologic data on the relationships of caloric intake, energy balance, and weight gain over the life span with longevity and morbidity. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 56 7-19.
106. Le Marchand L, Kolonel LN, Earle ME & Ming-Pi MI 1988 Body size at different periods of life and breast cancer risk. American Journal of Epidemiology 128 137-152.
107. Leung BS & Potter AH 1987 Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population. Journal of Cellular Biochemistry 34 213-225.
108. Levine L 2001 Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. Prostaglandins Leukotrienes and Essential Fatty Acids 65 229-232.
109. Lin S-Y, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG & Hung M-C 2000 Beta-catenin, a novel prognostic marker for breast cancer: its role in cyclin D1 expression and cancer progression. PNAS 97 4262-4266.
110. Lippman M & Bolan G 1975 Oestrogen-responsive human breast cancer in long term tissue culture. Nature 256 592-593.
111. Lippman M, Bolan G & Huff K 1976 The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long term tissue culture. Cancer Research 36 4595-4601.
112. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG & Kushner PJ 2002 Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. Journal of Biological Chemistry 277 24353-24360.
113. Lukas J, Bartkova J & Bartek J 1996 Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin dependent kinase-pRb-controlled G1 checkpoint. Molecular and Cellular Biology 16 6917-6925.
114. Luo J & Miller MW 2000 Ethanol enhances erbB-mediated migration of human breast cancer cells in culture. Breast Cancer Research and Treatment 63 61-69.
115. McCormack VA, dos Santos Silva I, De Stavola BL, Perry N, Vinnicombe S, Swerdlow AJ, Hardy R & Kuh D 2003 Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort. British Journal of Cancer 89 852-859.
116. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG & Yuasa S 1970 Age at first birth and breast cancer. Bulletin of the World Health Organization 43 209-221.
117. McMichael-Phillips DF, Harding C, Morton M, Robert SA, Howell A, Potten CS & Bundred NJ 1998 Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68 1431S-1436S.
118. Maggiolini M, Donze O, Jeannin E, Ando S & Picard D 1999 Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Cancer Research 59 4864-4869.
119. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D & Adami HO 1998 Body size in different periods of life and breast cancer risk in post-menopausal women. International Journal of Cancer 76 29-34.
120. Mangelsdorf DJ, Kliewer SA, Kakizuka A, Umesono K & Evans RM 1993 Retinoid receptors. Recent Progress in Hormone Research 48 99-121.
121. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL & Chodosh LA 1995 The developmental pattern of Brcal expression implies a role in differentiation of the breast and other tissues. Nature Genetics 11 17-26.
122. Marttunen MB, Andersson S, Hietanen P, Karonen SL, Koistinen HA, Koivisto VA, Tiitinen A & Ylikorkala O 2000 Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas 35 175-179.
123. Mellemkjaer L, Emborg C, Gridley G, Munk-Jorgensen P, Johansen C, Tjonneland A, Kjaer SK & Olsen JH 2001 Anorexia nervosa and cancer risk. Cancer Causes and Control 12 173-177.
124. Merry BJ 2002 Molecular mechanisms linking calorie restriction and longevity. International Journal of Biochemistry and Cellular Biology 34 1340-1354.
125. Messina M 1999 Soy, soy phytoestrogens (isoflavones), and breast cancer. American Journal of Clinical Nutrition 70 574-575.
126. Metz RP, Kaeck M, Stacewicz-Sapuntzakis M, Mitrenga T, McCarty H & Schedin P 2002 Adolescent vitamin A intake alters susceptibility to mammary carcinogenesis in the Sprague-Dawley rat. Nutrition and Cancer 42 78-90.
127. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA & Shay N 2003 Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. Journal of Nutrition 133 1238-1243.
128. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter D, Colditz GA, Hankinson SE, Speizer FE & Willett WC 1996 Birthweight as a risk factor for breast cancer. Lancet 348 1542-1546.
129. Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A & Wolk A 2001 Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. International Journal of Cancer 91 563-567.
130. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA & Manson JE 2003 Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26 1752-1758.
131. Migliaccio A, DiDomenico M, Castoria G, deFalco A, Bontempo P, Nola E & Auricchio F 1996 Tyrosine kinase/ p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 15 1292-1300.
132. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y & Noguchi S 2003 Association of serum adiponectin levels with breast cancer risk. Clinical Cancer Research 9 5699-5704.
133. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM & Arnold A 1991 A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350 512-515.
134. Mu YM, Yanase T, Nishi Y, Takayanagi R, Goto K & Nawata H 2001 Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Molecular and Cellular Endocrinology 181 239-248.
135. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S & Spiegelman BM 1998 Terminal differentiation of human breast cancer through PPARγ. Molecular Cell 1 1465-470.
136. Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr & Heyman RA 1997 Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386 407-410.
137. Muller P, Kietz S, Gustafsson JA & Strom A 2002 The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression. Journal of Biological Chemistry 277 28376-28379.
138. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S & Lamartiniere CA 1996 Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17 1451-1457.
139. Musgrove EA, Sarcevic B & Sutherland RL 1996 Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. Journal of Cellular Biochemistry 60 363-378.
140. Najid A & Habrioux G 1990 Biological effects of adrenal androgens on MCF-7 and BT-20 human breast cancer cells. Oncology 47 269-274.
141. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M & Ewen ME 1997 Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Molecular and Cellular Biology 17 5338-5347.
142. Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T & Wakabayashi K 2003 Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Research 63 6090-6095.
143. Nishiwaki E, Turner SL, Harju S, Miyazaki S, Kashiwagi M, Koh J & Serizawa H 2000 Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. Molecular and Cellular Biology 20 7726-7734.
144. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, Cooper DR & Yasuda K 2002 Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochimica et Biophysica Acta 1592 107-116.
145. Oza AM & Boyd NF 1993 Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiological Reviews 15 196-208.
146. Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y & Acikel C 2001 Effects of tamoxifen on the serum leptin level in patients with breast cancer. Japanese Journal of Clinical Oncology 31 424-427.
147. Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S, Kilic E & Halperin JA 2000 Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Research 60 2919-2925.
148. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D & Richardson BE 2002 Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiology, Biomarkers and Prevention 11 361-368.
149. Pestell RG, Albanese C, Reutens AT, Lee RJ, Segall J & Arnold A 1999 The cyclins and cyclin dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Reviews 20 501-534.
150. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M & Coward L 1996 Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 5 785-794.
151. Planas-Silva MD & Weinberg RA 1997 Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Molecular and Cellular Biology 17 4059-4069.
152. Potischman N & Troisi R 1999 In utero and early life exposures in relation to risk of breast cancer. Cancer Causes and Control 10 561-573.
153. Potischman N, Swanson CA, Siiteri P & Hoover RN 1996 Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. Journal of the National Cancer Institute 88 756-758.
154. Poulin R & Labrie F 1986 Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-71 human breast cancer cell line. Cancer Research 46 4933-4937.
155. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW & Sutherland RL 1997 Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E- Cdk2. Journal of Biological Chemistry 272 10882-10894.
156. Pratt MA, Bishop TE, White D, Yasvinski G, Menard M, Niu MY & Clarke R 2003 Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence. Molecular and Cellular Biology 23 6887-6900.
157. Razanamahefa L, Prouff S & Bardon S 2000 Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 nRNA expression. Nutrition and Cancer 38 274-280.
158. Riboli E & Norat T 2003 Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. American Journal of Clinical Nutrition 78 559S-569S.
159. Richards JA & Brueggemeier RW 2003 Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. Journal of Clinical Endocrinology and Metabolism 88 2810-2816.
160. Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE & Calvin JA 1998 Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. American Journal of Epidemiology 48 719-727.
161. Richardson S, Gerber M & Cenee S 1990 The role of fat, animal protein and some vitamin consumption in breast cancer: a case control study in southern France. International Journal of Cancer 48 1-9.
162. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palinski W & Glass CK 1998 Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. PNAS 95 7614-7619.
163. del Rincon SV, Rousseau C, Samanta R & Miller WH Jr 2003 Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. Oncogene 22 3353-3360.
164. Robsahm TE & Tretli S 2002 Breast cancer incidence in food- vs non-food-producing areas in Norway: possible beneficial effects of World War II. British Journal of Cancer 86 362-366.
165. Rose DP 1997 Dietary fatty acids and cancer. American Journal of Clinical Nutrition 66 998S-1003S.
166. Rose DP, Boyar AP, Cohen C & Strong LE 1987 Effect of a low-fat diet on hormone levels in women with cystic breast disease. Journal of the National Cancer Institute 78 623-626.
167. Rose DP, Connolly JM, Chlebowski RT, Buzzard IM & Wynder EL 1993 The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research and Treatment 27 253-262.
168. Rose DP, Connolly JM, Rayburn J & Coleman M 1995 Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. Journal of the National Cancer Institute 87 587-592.
169. Rosen ED & Spiegelman BM 2001a PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry 276 37731-37734.
170. Rosen ED & Spiegelman BM 2001b PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry 276 37731-37734.
171. Rosen EM, Fan S & Goldberg ID 2001 BRCA1 and prostate cancer. Cancer Investigation 19 396-412.
172. Roth GS, Ingram DK, Black A & Lane MA 2000 Effects of reduced energy intake on the biology of aging: the primate model. European Journal of Clinical Nutrition 54 (Suppl 3) S15-S20.
173. Rubin GL, Zhao Y, Kalus AM & Simpson ER 2000 Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Research 60 1604-1608.
174. Rubin GL, Duong JH, Clyne CD, Speed CJ, Murata Y, Gong C & Simpson ER 2002 Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose. Endocrinology 143 2863-2871.
175. Rudolph IL, Kelley DS, Klasing KC & Erickson KL 2001 Regulation of cellular differentiation and apoptosis by fatty acids and their metabolites. Nutrition Research 21 381-393.
176. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M & Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molecular Endocrinology 2 1157-1162.
177. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, Baird SM, Thomazy VA & Evans RM 1998 Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nature Medicine 4 1058-1061.
178. Sanderson M, Williams ML, Malone KE, Stanford JL, Emanuel I, White E & Daling J 1996 Perinatal factors and risk of breast cancer. Epidemiology 7 34-37.
179. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM & Eng C 1999 Loss-of-function mutations in PPAR gamma associated with human colon cancer. Molecular Cell 3 799-804.
180. Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE & Begg CB 2001 The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiology, Biomarkers and Prevention 10 467-473.
181. Seewaldt VL, Kim JH, Caldwell LE, Johnson BS, Swisshelm K & Collins SJ 1997 All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth and Differentiation 8 631-641.
182. Seewaldt VL, Dietze EC, Johnson BS, Collins SJ & Parker MB 1999 Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Cell Growth and Differentiation 10 49-59.
183. Shaag Y, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT & Zheng W 2001 Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiology, Biomarkers and Prevention 10 483-488.
184. Sherr CJ & Roberts JM 1999 CDK inhibitors:positive and negative regulators of G1-phase progression. Genes and Development 13 1501-1512.
185. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Miller AB, Potter JD, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A & Hunter DJ 2001 Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. Journal of the American Medical Association 285 769-776.
186. Sparano JA & Winer EP 2001 Liposomal anthracyclines for breast cancer. Seminars in Oncology 28 32-40.
187. Spillman M & Bowcock A 1996 BRCA1 and BRCA2 nRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13 1639-1645.
188. Stanley ER, Palmer RE & Sohn U 1977 Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells. Cell 10 35-44.
189. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y & Tataranni PA 2002 Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. Journal of Clinical Endocrinology and Metabolism 87 4652-4656.
190. Stripp C, Overvad K, Christensen J, Thomsen BL, Olsen A, Moller S & Tjonneland A 2003 Fish intake is positively associated with breast cancer incidence rate. Journal of Nutrition 133 3664-3669.
191. Suga K, Imai K, Eguchi H, Hayashi S, Higashi Y & Nakachi K 2001 Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Japanese Journal of Cancer Research 92 127-134.
192. Suh N, Wang Y, Williams CR, Risingsong R, Gilmer T, Willson TM & Sporn MB 1999 A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Research 59 5671-5673.
193. Swerdlow AJ, De Stavola BL, Floderus B, Holm NV, Kaprio J, Verkasalo PK & Mack T 2002 Risk factors for breast cancer at young ages in twins: an international population-based study. Journal of the National Cancer Institute 94 1238-1246.
194. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C & Mussa A 2000 Leptin expression in colorectal and breast cancer patients. International Journal of Molecular Medicine 5 421-426.
195. Thoennes SR, Tate PL, Price TM & Kilgore MW 2000 Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells. Molecular and Cellular Endocrinology 160 67-73.
196. Thompson HJ, Jiang W & Zhu Z 1999 Mechanisms by which energy restriction inhibits carcinogenesis. Advances In Experimental Medicine and Biology 470 77-84.
197. Toniolo PG, Levitz M, Zeleniuh-Jacquette A, Banerjee S, Koenig KL & Shore RE 1995 A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 87 190-197.
198. Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE & Riboli E 2001 Serum carotenoids and breast cancer. American Journal of Epidemiology 153 1142-1147.
199. Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER & Willett WC 1997 Body size and risk of breast cancer. American Journal of Epidemiology 145 1011-1019.
200. Trichopoulos D 1990 Hypothesis: does breast cancer originate in utero? Lancet 355 939-940.
201. Trichopoulos D, Polychronopoulou A, Brown J & MacMahon B 1983 Obesity, serum cholesterol, and estrogens in premenopausal women. Oncology 40 227-231.
202. Trock B, Butler LW, Clarke R & Hilakivi-Clarke L 2001 Meta-analysis of soy intake and breast cancer risk. Journal of Nutrition 130 690-691.
203. Van't Veer P, Kok FJ, Brants HAM, Ockhuizen T, Stumans F & Hermus RJJ 1990 Dietary fat and the risk of breast cancer. International Journal of Cancer 49 12-18.
204. Verhoeven DT, Assen N, Goldbohm RA, Dorant E, van' V, Sturmans F, Hermus RJ & van den Brandt PA 1997 Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. British Journal of Cancer 75 149-155.
205. Walker BE 1990 Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high fat diets. Journal of the National Cancer Institute 82 50-54.
206. Wang C, Fu M, D'Amico M, Albanese C, Zhou JN, Brownlee M, Lisanti MP, Chatterjee VK, Lazar MA & Pestell RG 2001 Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Molecular and Cellular Biology 21 3057-3070.
207. Wang C, Li Z, Fu M, Bouras T & Pestell RG 2003a Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: A molecular target with therapeutic potential, edn, pp 217-237 Ed. R Kumar. Dordrecht: Kluwer Academic Publisher.
208. Wang C, Pattabiraman N, Fu M, Zhou JN, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer P, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC & Pestell RG 2003b Cyclin D1 repression of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and transactivation. Molecular and Cellular Biology 23 6159-6173.
209. Wang TT, Sathyamoorthy N & Phang JM 1996 Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17 271-275.
210. Weinberg RA 1995 The retinoblastoma protein and cell cycle control. Cell 81 323-330.
211. Welsch CW 1987 Enhancement of mammary tumorigenesis by dietary fat: review of potential mechanisms. American Journal of Clinical Nutrition 45 192-202.
212. Welsch CW 1992 Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Research 52 2040-2048.
213. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA & King MC 2002 BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. PNAS 99 7560-7565.
214. Willett WC 1997 Specific fatty acids and risks of breast and prostate cancer: dietary intake. American Journal of Clinical Nutrition 66 1557S-1563S.
215. Willett WC 2001 Diet and breast cancer. Journal of Internal Medicine 249 395-411.
216. Willett WC & Hunter DJ 1994 Prospective studies of diet and breast cancer. Cancer 74 1085-1089.
217. Willett WC, Hunter DJ, Stampfer MJ, Colditz G, Manson JE, Spiegelman D, Rosner B, Hennekens CH & Speizer FE 1992 Dietary fat and fiber in relation to risk of breast cancer. Journal of the American Medical Association 268 2037-2044.
218. Wu AH, Pike MC & Stram DO 1999 Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. Journal of the National Cancer Institute 91 529-534.
219. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC & Pike MC 2002 Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 1491-1496.
220. Xu X, Wang HJ, Murphy PA, Cook L & Hendrich S 1994 Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. Journal of Nutrition 24 825-832.
221. Zafonte BT, Hulit J, Amanatullah DF, Albanese C, Wang C, Rosen E, Reutens A, Sparano JA, Lisanti MP & Pestell RG 2000 Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle. Frontiers in Bioscience: A Journal and Virtual Library 5 D938-D961.
222. Zava DT & Duwe G 1997 Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutrition and Cancer 27 31-40.
223. Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE & Willett WC 1999 Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. Journal of the National Cancer Institute 91 547-556.
224. Zhu Z, Jiang W & Thompson HJ 2002 An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Molecular Carcinogenesis 35 51-56.
225. Zhu Z, Jiang W & Thompson HJ 2003 Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas. Carcinogenesis 24 1225-1231.
226. Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R & Michalides RJAM 1997 CDK-independent activation of estrogen receptor by cyclin D1. Cell 88 405-415.